Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Platelet imipramine binding in intensive care unit suicidal patients

Summary

3H-Imipramine binding in relation to serotonergic function was studied in patients hospitalized following a suicide attempt. Comparison with a control group showed a highly significant difference in Bmax values. The results suggest, at least a posteriori, a biological alteration as the basis of suicidal behaviour. Although it is impossible to attribute a suicidal attempt to the alteration or to a predisposing pre-existent condition, this biological marker may be useful in evaluating suicidal risk and also short- and long-term prognosis.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Asberg M, Bertilsson L, Martensson B (1984) CSF monoamine metabolites depression, and suicide. In Frontiers in Biochemical and Pharmachological Research in Depression, Usdin E, Asberg M, Bertilsson L et al. (eds), Raven Press, New York

  2. 2.

    Praag HM Van, Haan S de (1979) Central serotonin metabolism and the frequency of depression. Psychiatry Res, 1:219–224

  3. 3.

    Weissman M, Fox K, Lerman GL (1973) Hostility and depression associated with suicide attempts. Am J Psychiatry, 130:450–455

  4. 4.

    Stanley M, Stanley B (1990) Postmortem evidence for serotonin's role in suicide. J Clin Psychiatry, 51:22–28

  5. 5.

    Sthal SM (1977) The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry, 34:509–516

  6. 6.

    Langer SZ, Raisman R, Briley MS et al. (1980) Platelets from depressed patients have a decreased number of 3H-Imipramine binding sites. Federal Proceedings, 30:1097–1102

  7. 7.

    Langer SZ, Raisman R (1983) High-affinity binding of 3H-imipramine and 3H-desipramine: Biochemical tools for studies in depression. Life Sci 29:211–220

  8. 8.

    Waegner A, Asberg-Wistedt A, Asberg M et al. (1985) Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls. Psychiatry Res 16:131–139

  9. 9.

    Roy A, Everett D, Pickar D et al. (1987) Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration. Arch Gen Psychiatry 44(4):320–327

  10. 10.

    WHO (1983) Collaborative study on the validity of the 3H-Imipramine platelet binding sites as a biological marker of endogenous depression. Technical Report

  11. 11.

    Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem, 83:346–352

  12. 12.

    De Leo D, Marazziti D (1988) Biological prediction of suicide: The role of serotonin. Crisis, 9/2:109–118

  13. 13.

    Ieni JR, Zukin SR, Praag HM Van (1985) Human platelets possess multiple 3H-Imipramine binding sites. Eur J Pharmacol, 106:669–672

  14. 14.

    Mellerup ET, Plenge P (1988) Imipramine binding in depression and other psychiatric conditions. Acta Psychiatr Scand, 78 (Suppl 345):61–68

  15. 15.

    Mann JJ, Arango V, Marzuk PM et al. (1989) Evidence for the 5-HT Hypothesis of suicide. A review of post-mortem studies. Br J Psychiatry, 155:7–14.

  16. 16.

    Hawton K, Fagg J (1988) Suicide and other causes of death, following attempted suicide. Br J Psychiatry, 152:359–366

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

De Leo, D., Caneva, A., Marazziti, D. et al. Platelet imipramine binding in intensive care unit suicidal patients. Eur Arch Psychiatry Clin Nuerosci 241, 85–87 (1991). https://doi.org/10.1007/BF02191146

Download citation

Key words

  • 3H-Imipramine binding sites
  • Attempted suicide
  • Biology of suicide